文献速递造血干细胞移植与细胞治疗

Lee症状量表-皮肤硬化版的开发:用于慢性移植物抗宿主病相关硬化症

Development of the Lee Symptom Scale-Skin Sclerosis for chronic GVHD-associated sclerosis.
PubMed 文献 · Blood · 2025-01-01

本研究旨在为慢性移植物抗宿主病(cGVHD)相关硬化症成人患者开发患者报告结局(PRO)工具。通过36例开放式访谈归纳出5个核心维度,经25例认知访谈对54个条目进行测试和修订,最终形成55条目的Lee症状量表-皮肤硬化版暂定版,其心理测量学检验正在进行中。

要点

  • 36例开放式访谈至饱和,归纳出皮肤改变、症状、情绪与社会功能、活动受限、日常活动限制5个维度。
  • 54个条目经25例认知访谈修订,删除1条、新增2条,最终形成55条目的暂定版量表。
  • 暂定版Lee症状量表-皮肤硬化版的相关性、可理解性和全面性得到支持,心理测量学检验正在进行中。

核心结论

  • 概念 elicitation 与认知访谈支持Lee症状量表-皮肤硬化版暂定版的相关性、可理解性和全面性,心理测量学检验及最小临床重要差异的确定正在外部队列中进行。

研究设计与样本

  • 纳入年龄≥18岁的cGVHD相关硬化症成人患者,进行半结构化访谈以识别突出症状和功能。
  • 共进行36例开放式访谈至饱和,并使用现有PRO中硬化症相关症状和功能提示讨论未自发提及的话题。
  • 通过归纳分析将重要症状和功能聚类映射至 overarching 维度并开发候选条目,再用认知访谈评估内容效度。
  • 认知访谈共25例,对54个条目池进行测试和迭代修订。

主要发现

  • 36例开放式访谈揭示cGVHD相关硬化症患者体验的5个 overarching 维度:皮肤改变、症状、情绪与社会功能、活动受限、日常活动限制。
  • 54个条目经25例认知访谈修订,调整措辞以提高相关性和可理解性,删除1条、新增2条,最终形成55个条目。

关键数值与推荐

  • 暂定版Lee症状量表-皮肤硬化版共55个条目。
  • 概念归纳出5个 overarching 维度:皮肤改变、症状、情绪与社会功能、活动受限、日常活动限制。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sclerosis is a highly morbid manifestation of chronic graft-versus-host disease (cGVHD), associated with distressing symptoms and significant long-term disability. A patient-reported outcome (PRO) measure for cGVHD-associated sclerosis is essential to advance therapeutic trials. We aimed to develop a PRO for adults with cGVHD-associated sclerosis and evaluate and refine its content validity. Adults aged ≥18 years with cGVHD-associated sclerosis participated in semistructured interviews to identify salient symptoms and functions. Sclerosis-relevant symptoms and functions from existing PROs were also used to prompt discussion of topics not spontaneously mentioned. Symptoms and functions (subcodes) of importance were clustered and mapped to overarching domains (codes) using inductive analysis, and candidate items were developed. Cognitive interviews were used to evaluate content validity of the items, response options, recall period, and respondent instructions. Thirty-six open-ended interviews, conducted to saturation, revealed the breadth of the patient experience with cGVHD-associated sclerosis including 5 overarching domains: (1) skin changes, (2) symptoms, (3) emotional and social functioning, (4) mobility restrictions, and (5) activity limitations. A pool of 54 items was tested and iteratively refined through cognitive debriefing interviews (n = 25). Phrasing changes were made to improve relevance and comprehension. One item was removed, and 2 items were added to address respondent feedback, resulting in 55 items. Results support the relevance, comprehensibility, and comprehensiveness of the provisional Lee Symptom Scale-Skin Sclerosis. Concept elicitation and cognitive interviewing have informed the development of the Lee Symptom Scale-Skin Sclerosis. Psychometric testing and determination of minimal clinically important differences are underway in an external cohort to validate the PROs.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Baumrin E, Pidala J, Mitchell SA, et al. Development of the Lee Symptom Scale-Skin Sclerosis for chronic GVHD-associated sclerosis. Blood. 2025. PMID: 39808799. doi:10.1182/blood.2024027334

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。